Intrinsic, an omni-channel consumer health company, today announced a $15 million equity fundraise to focus exclusively on women's health. The new capital, which brings the company's total funding to $128 million raised to date, includes participation from new investors FCA Venture Partners and MAP Investco, along with existing investors Define Ventures, Link Ventures, Redesign Health, and others.
Read MoreFCA Venture Partners (“FCA”), a leading healthcare technology venture capital firm, is pleased to announce the final close of FCA Venture Partners VII (“FCA VII”), with $90 million in capital commitments, well over the fund’s initial target of $75 million. FCA VII invests in Series A and Series B stage digital health and technology-enabled healthcare services companies that improve patient care, reduce costs, or increase efficiency.
Read MoreVirgo Surgical Video Solutions, Inc. ("Virgo") and The Clinical Trials Network ("CTNx") today announced a strategic partnership to expand and accelerate the identification, selection, and enrollment of patients in GI clinical trials across CTNx's expansive network of 30+ high-quality GI trial sites using Virgo's endoscopy data capture and artificial intelligence platform.
Read MoreFCA VI portfolio company, Enable Dental, is featured on House Calls, a podcast hosted by Cain Brothers, a division of KeyBanc Capital Markets, that explores some of the most interesting segments of healthcare and features organizations and business models that are helping to change the U.S. healthcare industry.
Read MoreAzra AI offered multiple technologies to help solve the complex problems, beginning with early identification of cancer patients through the use of artificial intelligence to surface positive cancer patients from pathological reports. Azra AI offered the ability to centralize the HCA division's data into essentially one platform from which staff could derive data to set service line goals and growth objectives with real-time data and volumes.
Read MoreFCA Venture Partners (“FCA”), a leading healthcare technology venture capital firm, is pleased to announce that FCA Health Innovations II (“FCA HI II”) held its final close with more than $71 million in capital commitments, well over the fund’s initial target of $50 million. With the launch of this fund, FCA HI II will continue its successful strategy in supporting Seed and Series A stage companies within the digital health and technology-enabled healthcare services landscape.
Read MoreCoachCare, a leading remote patient monitoring (RPM) and virtual health company, has acquired Winston-Salem based RPM company NVOLVE, for an undisclosed amount. Founded in 2014, NVOLVE’s expertise in the pain, spine and orthopedic specialties adds providers serving patients across North Carolina, South Carolina, Virginia, Georgia, Texas and Tennessee to CoachCare’s offerings.
Read More